Synthesis and biological study of novel indole-3-imine-2-on derivatives as src kinase and glutathione S-transferase inhibitors

dc.authorscopusid36188418100
dc.authorscopusid57198230646
dc.authorscopusid7801688219
dc.authorscopusid57190741107
dc.authorscopusid6701649928
dc.contributor.authorKurt,Z.K.
dc.contributor.authorAydin,D.
dc.contributor.authorIşgör,Y.G.
dc.contributor.authorIşgör,B.S.
dc.contributor.authorOlgen,S.
dc.date.accessioned2024-07-05T15:44:00Z
dc.date.available2024-07-05T15:44:00Z
dc.date.issued2013
dc.departmentAtılım Universityen_US
dc.department-tempKurt Z.K., Department of Pharmaceutical Chemistry, Faculty of Pharmacy, University of Ankara, 06100, Tandogan, Ankara, Turkey; Aydin D., Department of Pharmaceutical Chemistry, Faculty of Pharmacy, University of Ankara, 06100, Tandogan, Ankara, Turkey; Işgör Y.G., Chemistry Group, Faculty of Enginerring, Atilim University, 06836, Incek, Ankara, Turkey; Işgör B.S., Chemistry Group, Faculty of Enginerring, Atilim University, 06836, Incek, Ankara, Turkey; Olgen S., Department of Pharmaceutical Chemistry, Faculty of Pharmacy, University of Ankara, 06100, Tandogan, Ankara, Turkeyen_US
dc.description.abstractThe aim of this study is to design and synthesize novel dual inhibitors of Src protein tyrosine kinase (PTK) and Glutathione S-transferases (GSTs), as a potential drug lead with therapeutic efficacy on cancer and immune disorders. The biological activity profiling of small molecule inhibitors via miniaturized biochemical techniques compatible with medium throughput screening and focused screening methodologies were performed. To determining the effects of small molecule inhibitors on Src kinase and Phase II detoxification enzyme GST isozymes in liver homogenates used to verify their roles in drug resistance mechanism for cancer chemotherapeutics. In this study, 14 indole-3-imine-2-on and N-benzyl indole-3-imine-2-on derivatives were synthesized for dual activities against Src and GST. The chemical structures and purities of compounds were verified by IR, 1H NMR, MASS spectroscopy, and elemental analysis. The compounds 2, 3 and 9 are found slightly active against both enzyme Src and GST. © 2013 Bentham Science Publishers.en_US
dc.identifier.citation7
dc.identifier.doi10.2174/157018013804142456
dc.identifier.endpage26en_US
dc.identifier.issn1570-1808
dc.identifier.issue1en_US
dc.identifier.scopus2-s2.0-84875441230
dc.identifier.scopusqualityQ4
dc.identifier.startpage19en_US
dc.identifier.urihttps://doi.org/10.2174/157018013804142456
dc.identifier.urihttps://hdl.handle.net/20.500.14411/3711
dc.identifier.volume10en_US
dc.identifier.wosqualityQ4
dc.language.isoenen_US
dc.publisherBentham Science Publishersen_US
dc.relation.ispartofLetters in Drug Design and Discoveryen_US
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanıen_US
dc.rightsinfo:eu-repo/semantics/closedAccessen_US
dc.subjectCanceren_US
dc.subjectDrug resistanceen_US
dc.subjectGlutathion-S-transferaseen_US
dc.subjectIsatineen_US
dc.subjectSrc tyrosine kinaseen_US
dc.subjectSynthesisen_US
dc.titleSynthesis and biological study of novel indole-3-imine-2-on derivatives as src kinase and glutathione S-transferase inhibitorsen_US
dc.typeArticleen_US
dspace.entity.typePublication

Files

Collections